X T L Biopharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Alaunos Therapeutics USD 2K 0 2024-12
Bioline Rx USD 62.57M 24.47M 2025-03
Teva Pharmaceutical Industries USD 58M 0 2024-09
X T L Biopharmaceuticals USD 23.14M 0 2024-12



X T L Biopharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2025.